CHIRAL DRUG-METABOLISM - A PERSPECTIVE

被引：7

作者：

KAYE, B

机构：

来源：

BIOCHEMICAL SOCIETY TRANSACTIONS | 1991年 / 19卷 / 02期

关键词：

D O I：

10.1042/bst0190456

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：456 / 459

页数：4

共 15 条

[1]

BARTELS MJ, 1989, DRUG METAB DISPOS, V17, P286

[2] PHARMACOKINETICS OF (+)-HEXOBARBITONE, (-)-HEXOBARBITONE AND (+-]-HEXOBARBITONE IN MAN AFTER ORAL ADMINISTRATION [J].

BREIMER, DD ;

VANROSSU.JM .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (09) :762-764

[3] STEREOSELECTIVITY AND REGIOSELECTIVITY OF HEPATIC OXIDATION IN MAN - EFFECT OF THE DEBRISOQUINE SPARTEINE PHENOTYPE ON BUFURALOL HYDROXYLATION [J].

DAYER, P ;

LEEMANN, T ;

KUPFER, A ;

KRONBACH, T ;

MEYER, UA .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 31 (03) :313-318

[4]

HEIMARK LD, 1984, J MED CHEM, V27, P1092, DOI 10.1021/jm00374a027

[5]

KUNZE KL, 1983, J BIOL CHEM, V258, P4202

[6]

KUPFER A, 1981, J PHARMACOL EXP THER, V218, P193

[7] ABSOLUTE-CONFIGURATION OF (+)-5-(3-HYDROXYPHENYL)-5-PHENYLHYDANTOIN, MAJOR METABOLITE OF 5,5-DIPHENYLHYDANTOIN IN DOG [J].

MAGUIRE, JH ;

BUTLER, TC ;

DUDLEY, KH .

JOURNAL OF MEDICINAL CHEMISTRY, 1978, 21 (12) :1294-1297

[8]

NAKAMURA Y, 1980, P S DRUG METAB ACTIO, V12, pS1

[9] CRYSTAL-STRUCTURES OF METYRAPONE-INHIBITED AND PHENYLIMIDAZOLE-INHIBITED COMPLEXES OF CYTOCHROME-P-450CAM [J].

POULOS, TL ;

HOWARD, AJ .

BIOCHEMISTRY, 1987, 26 (25) :8165-8174

[10]

POULOS TL, 1985, J BIOL CHEM, V260, P6122

← 1 2 →